Based out of Singapore, she will lead the agency’s creative, content innovation and studio capabilities in the region to create data-driven creative innovation for Essence’s clients.
2021 0514 NUS and Shell join hands to advance decarbonisation solutions
The research agreement was inked by (front row, from left) Ms Emily Tan, General Manager, City Solutions, Shell Renewables and Energy Solutions, and Professor Chen Tsuhan, NUS Deputy President (Research and Technology). The signing was witnessed by (back row, from left) Professor Low Teck Seng, Chief Executive Officer, National Research Foundation Singapore, Ms Aw Kah Peng, Chairman, Shell Companies in Singapore, and Mr Chng Kai Fong, Managing Director, Singapore Economic Development Board.
Researchers from the National University of Singapore (NUS) and international energy giant Shell will jointly develop novel processes to use carbon dioxide, a byproduct of industrial processes, to produce fuels and chemicals for the energy industry. Supported by the National Research Foundation Singapore (NRF), this S$4.6 million research programme was formalised by all three parties at a ceremony held today.
BioNTech plant regionalen Hauptsitz für Südostasien und erste mRNA-Produktionsstätte in Singapur bionity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bionity.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing .
BioNTech SEMay 10, 2021 GMT
BioNTech to establish first regional hub in Asia Pacific region in Singapore
Planned state-of-the-art manufacturing site will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for south east Asia against potential future pandemic threats
Expansion plan supported by the Singapore Economic Development Board (EDB)
MAINZ, GERMANY, May 10, 2021 BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore. In addition to selecting Singapore as its future regional headquarters, BioNTech plans to establish a fully integrated mRNA manufacturing facility in Singapore
(2)
BioNTech to establish first regional hub in Asia Pacific region in Singapore
Planned state-of-the-art manufacturing site will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for south east Asia against potential future pandemic threats
Expansion plan supported by the Singapore Economic Development Board (EDB)
MAINZ, GERMANY, May 10, 2021 -
BioNTech SE(Nasdaq: BNTX, BioNTech or the Company ) today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore. In addition to selecting Singapore as its future regional headquarters, BioNTech plans to establish a fully integrated mRNA manufacturing facility in Singapore with support from the Singapore Economic Development Board. The new facility will provide regional and global supply capacity of BioNTech s growing pipeline of mRNA-based product candidates, as well as a rapid response production